Invention Grant
- Patent Title: Treatment of respiratory depression
-
Application No.: US14400343Application Date: 2013-05-10
-
Publication No.: US09610291B2Publication Date: 2017-04-04
- Inventor: David Cavalla
- Applicant: NUMEDICUS LIMITED
- Applicant Address: GB Cambridge
- Assignee: Numedicus Limited
- Current Assignee: Numedicus Limited
- Current Assignee Address: GB Cambridge
- Agency: McCarter & English, LLP
- Priority: GB1208315.0 20120511
- International Application: PCT/GB2013/051213 WO 20130510
- International Announcement: WO2013/167906 WO 20131114
- Main IPC: A61K31/554
- IPC: A61K31/554 ; C07D281/02 ; A61K45/06 ; A61K31/485
Abstract:
Tricyclic dibenzothiazepine compounds for use in the treatment of respiratory depression.
Public/Granted literature
- US20150141405A1 TREATMENT OF RESPIRATORY DEPRESSION Public/Granted day:2015-05-21
Information query
